New oral anticoagulants provide same stroke prevention as warfarin but cause less bleeding supriya kashyap kashyap29 Aug 2016 9:20 PM ISTItaly : The new oral anticoagulants provide the same stroke prevention as warfarin but cause less intracranial bleeding, reports an observational...
Underuse of Anti-Clotting Therapies Common among Patients with Atrial Fibrillation who Have a Stroke supriya kashyap kashyap14 March 2017 3:43 PM ISTInadequate use of anticoagulation therapies was prevalent among patients with atrial fibrillation who experienced a stroke, according to a study...
Dabigatran, Rivaroxaban, and Apixaban similarly effective in nonvalvular AF Medha Baranwal Baranwal24 July 2018 7:15 PM ISTThe risk for stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF) is not significantly different between 3 non-vitamin K...
Lower doses of NOACs don't increase risk of intracranial haemorrhage : JAMA Medha Baranwal Baranwal18 Sept 2018 7:20 PM ISTNOACs are an attractive option for stroke prevention in people without atrial fibrillation but may carry risks of intracranial haemorrhage. A new...
Is aspirin on its way out? Medha Baranwal Baranwal18 March 2019 7:03 PM ISTApixaban + Clopidogrel, best combo for atrial fibrillation (AF) patients undergoing angioplasty.More and more aging patients especially more than 70...
Chronic use of Vitamin K anticoagulants and antagonists increases bleeding risk after TAVR Deepanjana Sarkar18 Jun 2019 7:30 PM ISTFor patients in need of oral anticoagulants after transcatheter aortic valve replacement (TAVR), the chronic use of vitamin K oral anticoagulant...
Stent selection for PCI in high bleeding risk patients Medha Baranwal Baranwal13 July 2019 5:22 PM ISTWith an increase in population, more and more elderly patients are coming to cath lab with serious comorbidities causing a high degree of bleeding.The...
NOACs superior to vitamin K antagonists in early stage CKD Medha Baranwal Baranwal15 July 2019 9:00 AM ISTDelhi: Non-vitamin K oral anticoagulants (NOACs) are superior to vitamin K antagonists in benefit-risk profiles for the treatment of patients with...
